Biofil Chemicals & Pharmaceuticals Ltd EPS
Biofil Chemicals & Pharmaceuticals Ltd
NSE: BIOFILCHEM
EPS
Key Highlights
- The Earning per Share of Biofil Chemicals & Pharmaceuticals Ltd is ₹ 0.3 as of 08 Oct 26 The earning per share of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 0.1 to ₹ 0.07 over 9 quarters. This represents a CAGR of -14.66% .
Historical Earning per Share of Biofil Chemicals & Pharmaceuticals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Biofil Chemicals & Pharmaceuticals Ltd
Company Fundamentals for Biofil Chemicals & Pharmaceuticals Ltd
Market Cap
48 Cr
EPS
0.3
P/E Ratio (TTM)
98.3
P/B Ratio (TTM)
2.2
Day’s High
30.7
Day’s Low
29.5
DTE
0.1
ROE
12.9
52 Week High
46.82
52 Week Low
25.6
ROCE
14.1
Market Price of Biofil Chemicals & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 08 Oct 2026 | 29.5 |
| 07 Oct 2026 | 30.08 |
| 06 Oct 2026 | 30.38 |
| 05 Oct 2026 | 29.57 |
| 01 Oct 2026 | 29.64 |
| 30 Sep 2026 | 30.31 |
| 29 Sep 2026 | 31.82 |
| 28 Sep 2026 | 31.51 |
| 25 Sep 2026 | 32.75 |
| 24 Sep 2026 | 32.08 |
SWOT Analysis Of Biofil Chemicals & Pharmaceuticals Ltd
BlinkX Score for Biofil Chemicals & Pharmaceuticals Ltd
Asset Value vs Market Value of Biofil Chemicals & Pharmaceuticals Ltd
Market Value
₹ 48
Asset Value
Value addition
0.3 X
₹ 36
* All values are in ₹ crores
Competitive Comparison of EPS
| Company | Market Cap | EPS |
|---|
Biofil Chemicals & Pharmaceuticals Ltd | 48 | 0.3 |
Sun Pharmaceutical Industries Ltd | 420483 | 52.66 |
Divis Laboratories Ltd | 249248 | 112.23 |
Torrent Pharmaceuticals Ltd | 177822 | 58.66 |
Zydus Lifesciences Ltd | 111242 | 48.95 |
Laurus Labs Ltd | 108062 | 20.24 |
| Company | |
|---|---|
| Biofil Chemicals & Pharmaceuticals Ltd | 48 |
| Sun Pharmaceutical Industries Ltd | 420483 |
| Divis Laboratories Ltd | 249248 |
| Torrent Pharmaceuticals Ltd | 177822 |
| Zydus Lifesciences Ltd | 111242 |
| Laurus Labs Ltd | 108062 |
Historical Market Cap of Biofil Chemicals & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Biofil Chemicals & Pharmaceuticals Ltd
Historical Revenue of Biofil Chemicals & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Biofil Chemicals & Pharmaceuticals Ltd
Historical EBITDA of Biofil Chemicals & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Biofil Chemicals & Pharmaceuticals Ltd
Historical Net Profit of Biofil Chemicals & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Biofil Chemicals & Pharmaceuticals Ltd
Dividend Payout Over Time
Biofil Chemicals & Pharmaceuticals Ltd News Hub
Biofil Chemicals & Pharmaceuticals standalone net profit declines 29.17% in the June 2024 quarter
Net profit of Biofil Chemicals & Pharmaceuticals declined 29.17% to Rs 0.17 crore in the quarter end
Read more
14 Aug 24
Biofil Chemicals & Pharmaceuticals to table results
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1
Read more
12 Aug 24
Biofil Chemicals & Pharmaceuticals AGM scheduled
Biofil Chemicals & Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa
Read more
10 Sept 24
Biofil Chemicals & Pharmaceuticals to conduct board meeting
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1
Read more
08 Nov 24
